The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-11 of 11 articles
One-year outcomes in 1,010 unselected patients treated with the PROMUS Element everolimus-eluting stent: the multicentre PROMUS Element European Post-Approval Surveillance Study
Thomas M,
Birkemeyer R,
Schwimmbeck P,
Legrand V,
Moreno R,
Briguori C,
Werner N,
Bramucci E,
Ungi I,
Richardt G,
Underwood P,
Dawkins K
March 20, 2015 | 10.4244/EIJY15M01_07
Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial
Legrand V,
Cuisset T,
Chenu P,
Vrolix M,
Martinez C,
Dens J,
Gach O,
Boland J,
Claeys M,
Magne J,
Barbato E,
Wijns W
June 20, 2014 | 10.4244/EIJV10I2A34
Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry
Cuculi F,
Banning AP,
Abizaid A,
Bartorelli A,
Baux A,
Dzavik V,
Ellis S,
Gao R,
Holmes D,
Jeong M,
Legrand V,
Neumann F,
Nyakern M,
Spaulding C,
Stoll H,
Worthley SG,
Urban P
December 30, 2011 | 10.4244/EIJV7I8A152
Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial
Duckers H,
Houtgraaf J,
Hehrlein C,
Schofer J,
Waltenberger J,
Gershlick AH,
Bartunek J,
Nienaber C,
Naber C,
Macaya C,
Peters N,
Smits P,
Siminiak T,
van Mieghem W,
Legrand V,
Serruys P
February 21, 2011
Influence of age on the clinical outcomes of coronary revascularisation for the treatment of patients with multivessel de novo coronary artery lesions: sirolimus-eluting stent vs. coronary artery bypass surgery and bare metal stent, insight from the multicentre randomised Arterial Revascularisation Therapy Study Part I (ARTS-I) and Part II (ARTS-II)
Legrand V,
Garg S,
Serruys P,
Virtanen K,
Szurawitzki G,
Voudris V,
Fontanelli A,
Endersen K,
Kranjec I,
Rademaker T,
Stefanadis C,
Wittebols K
February 21, 2011
Meeting report. ESC Forum on Drug Eluting Stents, European Heart House, Nice, 27-28 September 2007
Daemen J,
Simoons M,
Wijns W,
Bagust A,
Bos G,
Bowen J,
Braunwald E,
Camenzind E,
Chevalier B,
Di Mario C,
Fajadet J,
Gitt A,
Guagliumi G,
Hillege H,
James S,
Jüni P,
Kastrati A,
Kloth S,
Kristensen S,
Krucoff M,
Legrand V,
Pfisterer M,
Rothman M,
Serruys P,
Silber S,
Steg PG,
Tariah I,
Wallentin L,
Windecker S
January 20, 2009
Percutaneous coronary intervention of bifurcation lesions: state-of-the-art. Insights from the second meeting of the European Bifurcation Club
Legrand V,
Thomas M,
Zelízko M,
De Bruyne B,
Reifart N,
Steigen T,
Hildick-Smith D,
Albiero R,
Darremont O,
Stankovic G,
Pan M,
Lassen J,
Louvard Y,
Lefèvre T
May 22, 2007
Percutaneous coronary interventions in Europe 1992-2003
Cook S,
Togni M,
Walpoth N,
Maier W,
Muehlberger V,
Legrand V,
Milicic D,
Zambartas C,
Zelízko M,
Madsen J-K,
van Buuren F,
López-Palop R,
Peeba M,
Koskenkorva J,
Vanhanen H,
Lablanche J,
Lazaris I,
Géza F,
Eyjolfsson K,
Kearney P,
Piscione F,
Erglis A,
Navickas R,
Beissel J,
Channam R,
Koch K,
Deleanu D,
Melberg T,
Witkowski A,
Pereira H,
Reho I,
Fridrich V,
Zorman D,
Nilsson T,
Oezmen F,
Ludman P,
Meier B
February 20, 2006
Latest news
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
Simultaneous Publications at EuroPCR 2023!
May 12, 2023
NEW ISSUE
Debating Invasive Coronary Testing in INOCA Patients; Single Antiplatelet Therapy After PCI; Ultrasound-Guided Femoral Access in the UNIVERSAL Trial
May 12, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023